Nutrivolatilomics of Urinary and Plasma Samples to Identify Candidate Biomarkers after Cheese, Milk, and Soy-Based Drink Intake in Healthy Humans.

VTT extraction biomarker cheese milk nutrition plasma metabolome soy-based drink urinary metabolome volatilomics

Journal

Journal of proteome research
ISSN: 1535-3907
Titre abrégé: J Proteome Res
Pays: United States
ID NLM: 101128775

Informations de publication

Date de publication:
02 10 2020
Historique:
pubmed: 4 9 2020
medline: 22 6 2021
entrez: 4 9 2020
Statut: ppublish

Résumé

The characterization of volatile compounds in biological fluids offers a distinct approach to study the metabolic imprint of foods on the human metabolome, particularly to identify novel biomarkers of food intake (BFIs) that are not captured by classic metabolomics. Using a combination of dynamic headspace vacuum transfer In Trap extraction and gas chromatography coupled with mass spectrometry, we measured volatile compounds (the "volatilome") in plasma and urine samples from a randomized controlled crossover intervention study in which 11 healthy subjects ingested milk, cheese, or a soy-based drink. More than 2000 volatile compounds were detected in plasma, while 1260 compounds were detected in urine samples. A postprandial response in plasma was confirmed for 697 features. Univariate and multivariate analyses identified four molecules in plasma and 31 molecules in urine samples differentiating the ingestion of the foods, of which three metabolites in plasma and nine in urine were specific to the dairy products. Among these molecules, heptan-2-one, 3,5-dimethyloctan-2-one, and undecan-2-one in plasma and 3-ethylphenol, heptan-2-one, 1-methoxy-2-propyl acetate, and 9-decenoic acid were highly discriminative for dairy or cheese intake. In urine, 22 volatile compounds were highly discriminative for soy-based drink intake. The majority of these molecules have not been reported in humans. Our findings highlight the potential of plasma and urinary volatilomics for detection of novel dietary biomarkers.

Identifiants

pubmed: 32880181
doi: 10.1021/acs.jproteome.0c00324
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4019-4033

Auteurs

Pascal Fuchsmann (P)

Agroscope, Schwarzenburgstrasse 161, 3003 Bern, Switzerland.

Mireille Tena Stern (M)

Agroscope, Schwarzenburgstrasse 161, 3003 Bern, Switzerland.

Linda H Münger (LH)

Agroscope, Schwarzenburgstrasse 161, 3003 Bern, Switzerland.

Grégory Pimentel (G)

Agroscope, Schwarzenburgstrasse 161, 3003 Bern, Switzerland.

Kathryn J Burton (KJ)

Agroscope, Schwarzenburgstrasse 161, 3003 Bern, Switzerland.

Nathalie Vionnet (N)

Service of Endocrinology, Diabetes and Metabolism, Lausanne University Hospital, 1011 Lausanne, Switzerland.

Guy Vergères (G)

Agroscope, Schwarzenburgstrasse 161, 3003 Bern, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH